Pinnacle Associates’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,298
Closed -$280K 898
2024
Q3
$280K Buy
2,298
+252
+12% +$27.5K ﹤0.01% 692
2024
Q2
$222K Sell
2,046
-278
-12% -$32.8K ﹤0.01% 756
2024
Q1
$307K Buy
2,324
+26
+1% +$3.25K ﹤0.01% 698
2023
Q4
$280K Buy
2,298
+278
+14% +$31K ﹤0.01% 702
2023
Q3
$227K Buy
2,020
+97
+5% +$12.3K ﹤0.01% 734
2023
Q2
$280K Buy
1,923
+375
+24% +$51K ﹤0.01% 688
2023
Q1
$200K Sell
1,548
-3,842
-71% -$482K ﹤0.01% 727
2022
Q4
$687K Buy
5,390
+113
+2% +$13.1K 0.02% 456
2022
Q3
$552K Buy
5,277
+711
+16% +$78K 0.01% 480
2022
Q2
$480K Sell
4,566
-335
-7% -$39.7K 0.01% 526
2022
Q1
$627K Buy
4,901
+1,158
+31% +$140K 0.01% 516
2021
Q4
$462K Buy
3,743
+1,450
+63% +$190K 0.01% 571
2021
Q3
$326K Buy
2,293
+876
+62% +$129K 0.01% 628
2021
Q2
$221K Buy
+1,417
New +$230K ﹤0.01% 712

Other funds holding ZBH

Pinnacle Associates's ZBH Position: Q4 2024 in Review

Pinnacle Associates sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 2,298 shares — an estimated $280K sold.

Pinnacle Associates first reported a position in ZBH in Q2 2021 and held it in 14 quarters. The position peaked at $687K in Q4 2022. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Pinnacle Associates reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Pinnacle Associates sold 2,298 Zimmer Biomet shares in Q4 2024, an estimated $280K.
  • Pinnacle Associates first reported a position in Zimmer Biomet in Q2 2021 and held it in 14 quarters.
  • Pinnacle Associates's Zimmer Biomet position peaked at $687K in Q4 2022.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Pinnacle Associates's 13F filing for Q4 2024, filed 14 Feb 2025.